Spleen tyrosine kinase: a novel pharmacological target for sepsis-induced cardiac dysfunction and multi-organ failure
Sepsis is a systemic condition caused by a dysregulated host response to infection and often associated with excessive release of proinflammatory cytokines resulting in multi-organ failure (MOF), including cardiac dysfunction. Despite a number of effective supportive treatments (e.g. ventilation, di...
Saved in:
| Main Authors: | Chiara Verra, Maria Kerstin Paulmann, Jamila Wegener, Enrica Marzani, Gustavo Ferreira Alves, Massimo Collino, Sina Maren Coldewey, Christoph Thiemermann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1447901/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RETRACTED: Baricitinib protects mice from sepsis-induced cardiac dysfunction and multiple-organ failure
by: Chiara Verra, et al.
Published: (2023-09-01) -
Myeloid and Lymphoid Malignancies with Fusion Kinases Involving Spleen Tyrosine Kinase (SYK)—Emerging Rare Entities?
by: Velizar Shivarov, et al.
Published: (2025-06-01) -
Spleen tyrosine kinase inhibitors disrupt human neutrophil swarming and antifungal functions
by: Alex Hopke, et al.
Published: (2025-01-01) -
Expression of variant isoforms of the tyrosine kinase SYK differentially regulates cervical cancer progression through PI3K/AKT pathway
by: Bingjie Lin, et al.
Published: (2024-11-01) -
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination
by: Sebastian J Theobald, et al.
Published: (2022-07-01)